Ikarian Capital »

Ionis Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $28M 429k 65.42
2021-03-31 $4.0M 90k 44.97
2020-12-31 $16M 290k 56.54

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Ionis Pharmaceuticals

FMR
Vanguard Group
T. Rowe Price Investment Management
Capital World Investors
BlackRock
Wellington Management Company
Lombard Odier Asset Management
Bellevue Group
State Street Corporation
Deep Track Capital
Geode Capital Management
Tweedy, Browne Company
Citadel Advisors
Two Sigma Advisers
Deerfield Management Company

View all funds holding Ionis Pharmaceuticals